Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

G Kampf, D Todt, S Pfaender, E Steinmann, G Kampf, D Todt, S Pfaender, E Steinmann

Abstract

Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.

Keywords: Biocidal agents; Chemical inactivation; Coronavirus; Disinfection; Inanimate surfaces; Persistence.

Copyright © 2020 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

References

    1. WHO . WHO; 2020. Coronavirus Disease 2019 (COVID-19) Situation Report 23.
    1. de Wit E., van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–534.
    1. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 doi: 10.1016/s0140-6736(20)30154-9.
    1. Otter J.A., Donskey C., Yezli S., Douthwaite S., Goldenberg S.D., Weber D.J. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92:235–250.
    1. Dowell S.F., Simmerman J.M., Erdman D.D., Wu J.S., Chaovavanich A., Javadi M. Severe acute respiratory syndrome coronavirus on hospital surfaces. Clin Infect Dis. 2004;39:652–657.
    1. Geller C., Varbanov M., Duval R.E. Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies. Viruses. 2012;4:3044–3068.
    1. Kampf G. Springer International Publishing; Cham: 2018. Antiseptic stewardship: biocide resistance and clinical implications.
    1. Ijaz M.K., Brunner A.H., Sattar S.A., Nair R.C., Johnson-Lussenburg C.M. Survival characteristics of airborne human coronavirus 229E. J Gen Virol. 1985;66(Pt 12):2743–2748.
    1. Bean B., Moore B.M., Sterner B., Peterson L.R., Gerding D.N., Balfour H.H. Survival of influenza viruses an environmental surfaces. J Infect Dis. 1982;146:47–51.
    1. Ansari S.A., Springthorpe V.S., Sattar S.A., Rivard S., Rahman M. Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14. J Clin Microbiol. 1991;29:2115–2119.
    1. Kwok Y.L., Gralton J., McLaws M.L. Face touching: a frequent habit that has implications for hand hygiene. Am J Infect Contr. 2015;43:112–114.
    1. WHO . WHO; 2020. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Interim guidance. 25 January 2020.
    1. WHO. Annex G . WHO; Geneva: 2014. Use of disinfectants: alcohol and bleach. Infection prevention and control of epidemic-and pandemic-prone acute respiratory infections in health care; pp. 65–66.
    1. Siddharta A., Pfaender S., Vielle N.J., Dijkman R., Friesland M., Becker B. Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses. J Infect Dis. 2017;215:902–906.
    1. Yen M.Y., Lu Y.C., Huang P.H., Chen C.M., Chen Y.C., Lin Y.E. Quantitative evaluation of infection control models in the prevention of nosocomial transmission of SARS virus to healthcare workers: implication to nosocomial viral infection control for healthcare workers. Scand J Infect Dis. 2010;42:510–515.
    1. Alshammari M., Reynolds K.A., Verhougstraete M., O'Rourke M.K. Comparison of perceived and observed hand hygiene compliance in healthcare workers in MERS-CoV endemic regions. Healthcare (Basel, Switzerland) 2018;6:122.
    1. Al-Tawfiq J.A., Abdrabalnabi R., Taher A., Mathew S., Rahman K.A. Infection control influence of Middle East respiratory syndrome coronavirus: A hospital-based analysis. Am J Infect Contr. 2019;47:431–434.
    1. Wong T.W., Tam W.W. Handwashing practice and the use of personal protective equipment among medical students after the SARS epidemic in Hong Kong. Am J Infect Contr. 2005;33:580–586.
    1. Wiboonchutikul S., Manosuthi W., Likanonsakul S., Sangsajja C., Kongsanan P., Nitiyanontakij R. Lack of transmission among healthcare workers in contact with a case of Middle East respiratory syndrome coronavirus infection in Thailand. Antimicrob Resist Infect Control. 2016;5:21.
    1. Ki H.K., Han S.K., Son J.S., Park S.O. Risk of transmission via medical employees and importance of routine infection-prevention policy in a nosocomial outbreak of Middle East respiratory syndrome (MERS): a descriptive analysis from a tertiary care hospital in South Korea. BMC Pulm Med. 2019;19:190.
    1. van Doremalen N., Bushmaker T., Munster V.J. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill. 2013;18
    1. Casanova L.M., Jeon S., Rutala W.A., Weber D.J., Sobsey M.D. Effects of air temperature and relative humidity on coronavirus survival on surfaces. Appl Environ Microbiol. 2010;76:2712–2717.
    1. Warnes S.L., Little Z.R., Keevil C.W. Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials. mBio. 2015;6:e01697–15.
    1. Sizun J., Yu M.W., Talbot P.J. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections. J Hosp Infect. 2000;46:55–60.
    1. Duan S.M., Zhao X.S., Wen R.F., Huang J.J., Pi G.H., Zhang S.X. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci. 2003;16:246–255.
    1. Lai M.Y., Cheng P.K., Lim W.W. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis. 2005;41:e67–e71.
    1. Chan K.H., Peiris J.S., Lam S.Y., Poon L.L., Yuen K.Y., Seto W.H. The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus. Adv Virol. 2011:734690.
    1. Rabenau H.F., Cinatl J., Morgenstern B., Bauer G., Preiser W., Doerr H.W. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol. 2005;194:1–6.
    1. Rabenau H.F., Kampf G., Cinatl J., Doerr H.W. Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect. 2005;61:107–111.
    1. Saknimit M., Inatsuki I., Sugiyama Y., Yagami K. Virucidal efficacy of physico-chemical treatments against coronaviruses and parvoviruses of laboratory animals. Jikken Dobutsu Exp Anim. 1988;37:341–345.
    1. Wood A., Payne D. The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses. J Hosp Infect. 1998;38:283–295.
    1. Pratelli A. Action of disinfectants on canine coronavirus replication in vitro. Zoonoses Publ Health. 2007;54:383–386.
    1. Dellanno C., Vega Q., Boesenberg D. The antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus. Am J Infect Control. 2009;37:649–652.
    1. Omidbakhsh N., Sattar S.A. Broad-spectrum microbicidal activity, toxicologic assessment, and materials compatibility of a new generation of accelerated hydrogen peroxide-based environmental surface disinfectant. Am J Infect Control. 2006;34:251–257.
    1. Pratelli A. Canine coronavirus inactivation with physical and chemical agents. Vet J (London, England : 1997) 2008;177:71–79.
    1. Kariwa H., Fujii N., Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatol (Basel, Switzerland) 2006;212(Suppl 1):119–123.
    1. Eggers M., Eickmann M., Zorn J. Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA) Infect Dis Ther. 2015;4:491–501.
    1. Eggers M., Koburger-Janssen T., Eickmann M., Zorn J. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infect Dis Ther. 2018;7:249–259.
    1. Hulkower R.L., Casanova L.M., Rutala W.A., Weber D.J., Sobsey M.D. Inactivation of surrogate coronaviruses on hard surfaces by health care germicides. Am J Infect Control. 2011;39:401–407.
    1. Sattar S.A., Springthorpe V.S., Karim Y., Loro P. Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses. Epidemiol Infect. 1989;102:493–505.
    1. Goyal S.M., Chander Y., Yezli S., Otter J.A. Evaluating the virucidal efficacy of hydrogen peroxide vapour. J Hosp Infect. 2014;86:255–259.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa